D’Angelo, Alberto

Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy

Sirico, M., D’Angelo, A., Gianni, C., Casadei, C., Merloni, F., & De Giorgi, U. (2023) · Cancers

PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and Cancer

Cited by 121

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer

Roviello, G., Ramello, M., Catalano, M., D’Angelo, A., Conca, R., Gasperoni, S., Dreoni, L., Petrioli, R., Ianza, A., Nobili, S., et al. (2020) · Scientific Reports

Pancreatic and Hepatic Oncology ResearchCancer Treatment and Pharmacology

Cited by 16